Home | Welcome to Contract Pharma   
Last Updated Friday, October 31 2014
Print

Breaking News

Related Searches:
April 6, 2011
Camargo Pharmaceutical Services has opened a new office in Research Triangle Park (RTP), NC in order to provide additional service offerings, as well as streamline client services.   Read More »
April 6, 2011
Aptiv Solutions has created an Adaptive Clinical Trials Innovation Center comprised of thought leaders and experts in adaptive trial design, methodology and implementation.   Read More »
April 6, 2011
Lupin Ltd. has granted Salix Pharmaceuticals, Ltd. exclusive worldwide rights (except for India) to use Lupin technology for all rifaximin products for human use.   Read More »
April 6, 2011
Optimer Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Inc. have signed an exclusive two-year co-promotion agreement to market Dificid in the U.S.  Read More »
April 5, 2011
$430 million play boosts ophthalmology platform  Read More »
April 5, 2011
Evans Analytical Group, Inc. (EAG) has acquired Chemir Analytical Services and its affiliates CAS-MI Laboratories and Cyanta Analytical Services.  Read More »
April 5, 2011
Peter J. Hansbury, RPh has been appointed vice president of aseptic services at AMRI.  Read More »
April 5, 2011
Kevin Longe has been appointed president of Tegrant Corp.’s ThermoSafe Brands business unit.  Read More »
April 5, 2011
Aegis Analytical Corp. has partnered with CTC Laboratory Systems Corp. (CTCLS), a solutions provider in Japan, to help sell Aegis' Discoverant software and oversee product implementations and customer support in Japan.   Read More »
April 5, 2011
Morphotek, Inc., a subsidiary of Eisai Inc., has acquired certain assets to a tumor-targeting platform from TransMolecular, Inc. (TMI) for an undisclosed upfront payment and development milestones.  Read More »
April 4, 2011
Pfizer has entered an agreement with private equity firm KKR & Co. to sell its Capsugel unit for approximately $2.4 billion.   Read More »
April 4, 2011
John P. Gargiulo has been appointed president and chief executive officer of Daiichi Sankyo, Inc. (DSI), the U.S. division of Daiichi Sankyo Co. Ltd.  Read More »
April 4, 2011
MedImmune, AstraZeneca’s biologics business, and Inserm Transfert have entered a three-year strategic research collaboration for a range of therapeutic areas including oncology, respiratory, inflammation, and autoimmune diseases.  Read More »
April 4, 2011
Avanir Pharmaceuticals, Inc. has filed an IND application with the FDA to begin a large Phase II trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS).   Read More »
April 1, 2011
Invida Group Pte Ltd. has entered into a partnership agreement with Roche for the commercialization and marketing of Roche’s primary care portfolio throughout Korea.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On